This IDC Health Insights report is the first of a three-part life science R&D IDC MarketScape series focused on IT outsourcing. With a specific focus on life science R&D IT BPO, this report seeks to determine how the major IT vendors compare with each other, building on criteria that should be important to life science companies when considering the selection of an external service provider to take over noncore business processes. IDC MarketScape assessment of IT outsourcing in life science R&D was previously performed in 2011 and 2013.
Alan Louie, research director of IDC Health Insights' Life Science R&D Technology and Strategy Research, noted, "While still somewhat smaller than its traditional IT outsourcing counterpart, BPO in the life sciences continues to grow as companies have embraced externalization of noncore competencies and continue to seek direct cost savings and optimize operational agility within their organizations. The scope of life science R&D BPO continues to expand as more and more processes are operationalized and preferred IT partners are tasked with implementing and maintaining new processes and procedures (e.g., risk-based monitoring). As a result, leading IT service providers are increasingly being relied upon to help organizations implement ongoing organizational and process innovation through IT strategic consulting, IT development and support, and finally business process services. With mature industry-specific knowledge and experience in place, the life science R&D BPO IT vendor ecosystem can be expected to continue its double-digit growth for at least the next 5–10 years."
Indegene Lifesystems Pvt Ltd., Wipro Limited, Tata Group, Cognizant Technology Solutions Corporation, Accenture plc, iGate Corporation, Citigroup Global Services Limited, Computer Sciences Corporation